<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://podcastdemedicina.com/cp/wp-content/plugins/seriously-simple-podcasting/templates/feed-stylesheet.xsl?v=2"?><rss version="2.0"
	 xmlns:content="http://purl.org/rss/1.0/modules/content/"
	 xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	 xmlns:dc="http://purl.org/dc/elements/1.1/"
	 xmlns:atom="http://www.w3.org/2005/Atom"
	 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	 xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
	 xmlns:podcast="https://podcastindex.org/namespace/1.0"
	 xmlns:ssp="https://castos.com/seriously-simple-podcasting/namespace/1.0"
	>
		<channel>
		<title>MDS PODCAST: Defining Parkinson&#039;s disease</title>
		<atom:link href="https://podcastdemedicina.com/feed/podcast/mds-podcast-defining-parkinsons-disease/" rel="self" type="application/rss+xml"/>
		<link>https://podcastdemedicina.com/series/mds-podcast-defining-parkinsons-disease/</link>
		<description></description>
		<lastBuildDate>Fri, 20 Nov 2026 08:52:18 +0000</lastBuildDate>
		<language>es</language>
		<copyright>&#xA9; 2026 Podcast de Medicina · by casiMedicos</copyright>
		<itunes:subtitle>Plataforma de podcasts de medicina, salud y ciencia en formato audio, orientada a profesionales sanitarios, residentes MIR y estudiantes.</itunes:subtitle>
		<itunes:author>Podcast de Medicina · by casiMedicos</itunes:author>
		<itunes:summary></itunes:summary>
		<itunes:owner>
			<itunes:name>Podcast de Medicina · by casiMedicos</itunes:name>
		</itunes:owner>
		<itunes:explicit>false</itunes:explicit>
		<googleplay:author><![CDATA[Podcast de Medicina · by casiMedicos]]></googleplay:author>
						<googleplay:description></googleplay:description>
			<googleplay:explicit>No</googleplay:explicit>
			<podcast:locked>yes</podcast:locked>
		<podcast:guid>4eda0bf4-6e4e-586a-903c-7d2847c32eee</podcast:guid>
		
		<!-- podcast_generator="SSP by Castos/3.17.1" Seriously Simple Podcasting plugin for WordPress (https://wordpress.org/plugins/seriously-simple-podcasting/) -->
		<generator>https://wordpress.org/?v=7.1.5</generator>

<item>
	<title>MDS Podcast MDJ Research Article of the Year: Cognitive Phenotyping Via Digital Analysis of Spoken Word Properties</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-mdj-research-article-of-the-year-cognitive-phenotyping-via-digital-analysis-of-spoken-word-properties/</link>
	<pubDate>Mon, 09 Nov 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-mdj-research-article-of-the-year-cognitive-phenotyping-via-digital-analysis-of-spoken-word-properties/</guid>
	<description><![CDATA[In this episode, Dr. Michele Matarazzo interviews Dr. Adolfo M. García, senior author of the MDJ Research Article of the Year in Movement Disorders. They discuss how automated analysis of verbal fluency tasks in 464 Spanish-speaking people with Parkinson&#8217;s disease can predict global cognition and identify mild cognitive impairment more accurately than simple word counts,...]]></description>
	<itunes:subtitle><![CDATA[In this episode, Dr. Michele Matarazzo interviews Dr. Adolfo M. García, senior author of the MDJ Research Article of the Year in Movement Disorders. They discuss how automated analysis of verbal fluency tasks in 464 Spanish-speaking people with Parkinson]]></itunes:subtitle>
	<content:encoded><![CDATA[In this episode, Dr. Michele Matarazzo interviews Dr. Adolfo M. García, senior author of the MDJ Research Article of the Year in Movement Disorders. They discuss how automated analysis of verbal fluency tasks in 464 Spanish-speaking people with Parkinson&#8217;s disease can predict global cognition and identify mild cognitive impairment more accurately than simple word counts,...]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/riverside_michele_matarazzo_raw-audio_mds_podcast_-matara_0079.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode, Dr. Michele Matarazzo interviews Dr. Adolfo M. García, senior author of the MDJ Research Article of the Year in Movement Disorders. They discuss how automated analysis of verbal fluency tasks in 464 Spanish-speaking people with Parkinson&#8217;s disease can predict global cognition and identify mild cognitive impairment more accurately than simple word counts,...]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[In this episode, Dr. Michele Matarazzo interviews Dr. Adolfo M. García, senior author of the MDJ Research Article of the Year in Movement Disorders. They discuss how automated analysis of verbal fluency tasks in 464 Spanish-speaking people with Parkinson&#8217;s disease can predict global cognition and identify mild cognitive impairment more accurately than simple word counts,...]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast MDJ Review Article of the Year: Beyond Go and No-Go: Rethinking the Basal Ganglia</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-mdj-review-article-of-the-year-beyond-go-and-no-go-rethinking-the-basal-ganglia/</link>
	<pubDate>Mon, 09 Nov 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-mdj-review-article-of-the-year-beyond-go-and-no-go-rethinking-the-basal-ganglia/</guid>
	<description><![CDATA[The classic direct and indirect pathways of the basal ganglia are often taught as simple “Go” and “No-Go” systems for movement. But emerging evidence reveals a much richer picture. Dr. Michele Matarazzo speaks with Dr. Ann Graybiel about her 2026 Review Article of the Year Paper in Movement Disorders, exploring how basal ganglia circuits contribute...]]></description>
	<itunes:subtitle><![CDATA[The classic direct and indirect pathways of the basal ganglia are often taught as simple “Go” and “No-Go” systems for movement. But emerging evidence reveals a much richer picture. Dr. Michele Matarazzo speaks with Dr. Ann Graybiel about her 2026 Review ]]></itunes:subtitle>
	<content:encoded><![CDATA[The classic direct and indirect pathways of the basal ganglia are often taught as simple “Go” and “No-Go” systems for movement. But emerging evidence reveals a much richer picture. Dr. Michele Matarazzo speaks with Dr. Ann Graybiel about her 2026 Review Article of the Year Paper in Movement Disorders, exploring how basal ganglia circuits contribute...]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-ep-338_-MDJ-Review-Article-of-the-Year_-Surprises-From-the-Basal-Ganglia.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[The classic direct and indirect pathways of the basal ganglia are often taught as simple “Go” and “No-Go” systems for movement. But emerging evidence reveals a much richer picture. Dr. Michele Matarazzo speaks with Dr. Ann Graybiel about her 2026 Review Article of the Year Paper in Movement Disorders, exploring how basal ganglia circuits contribute...]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[The classic direct and indirect pathways of the basal ganglia are often taught as simple “Go” and “No-Go” systems for movement. But emerging evidence reveals a much richer picture. Dr. Michele Matarazzo speaks with Dr. Ann Graybiel about her 2026 Review Article of the Year Paper in Movement Disorders, exploring how basal ganglia circuits contribute...]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Hot Topic: Environmental toxicants and their role in Parkinson&#8217;s disease</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-hot-topic-environmental-toxicants-and-their-role-in-parkinsons-disease/</link>
	<pubDate>Mon, 02 Nov 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-hot-topic-environmental-toxicants-and-their-role-in-parkinsons-disease/</guid>
	<description><![CDATA[Dr. Ray Dorsey passionately shares the mounting evidence supporting the role environmental neuro-toxicants have in the development of Parkinson&#8217;s disease (PD) and why PD prevention deserves our attention. Read the article.]]></description>
	<itunes:subtitle><![CDATA[Dr. Ray Dorsey passionately shares the mounting evidence supporting the role environmental neuro-toxicants have in the development of Parkinson&#8217;s disease (PD) and why PD prevention deserves our attention. Read the article.]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Ray Dorsey passionately shares the mounting evidence supporting the role environmental neuro-toxicants have in the development of Parkinson&#8217;s disease (PD) and why PD prevention deserves our attention. Read the article.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-Ep-337---Hot-Topic_-Environmental-toxicants-and-their-role-in-Parkinsons-disease.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Ray Dorsey passionately shares the mounting evidence supporting the role environmental neuro-toxicants have in the development of Parkinson&#8217;s disease (PD) and why PD prevention deserves our attention. Read the article.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Ray Dorsey passionately shares the mounting evidence supporting the role environmental neuro-toxicants have in the development of Parkinson&#8217;s disease (PD) and why PD prevention deserves our attention. Read the article.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast AI and Wearable Devices: Potential and Pitfalls  &#124; Congress 2026</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-ai-and-wearable-devices-potential-and-pitfalls-congress-2026/</link>
	<pubDate>Mon, 26 Oct 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-ai-and-wearable-devices-potential-and-pitfalls-congress-2026/</guid>
	<description><![CDATA[Dr. Mitra Afshari discusses with Dr. Jeffrey Hausdorff the potential of AI-enabled digital biomarkers in Parkinson’s disease, including their role in patient monitoring, challenges in accuracy and reliability, and barriers to clinical implementation.]]></description>
	<itunes:subtitle><![CDATA[Dr. Mitra Afshari discusses with Dr. Jeffrey Hausdorff the potential of AI-enabled digital biomarkers in Parkinson’s disease, including their role in patient monitoring, challenges in accuracy and reliability, and barriers to clinical implementation.]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Mitra Afshari discusses with Dr. Jeffrey Hausdorff the potential of AI-enabled digital biomarkers in Parkinson’s disease, including their role in patient monitoring, challenges in accuracy and reliability, and barriers to clinical implementation.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/AI-and-Wearable-Devices_-Potential-and-Pitfalls.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Mitra Afshari discusses with Dr. Jeffrey Hausdorff the potential of AI-enabled digital biomarkers in Parkinson’s disease, including their role in patient monitoring, challenges in accuracy and reliability, and barriers to clinical implementation.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Mitra Afshari discusses with Dr. Jeffrey Hausdorff the potential of AI-enabled digital biomarkers in Parkinson’s disease, including their role in patient monitoring, challenges in accuracy and reliability, and barriers to clinical implementation.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Functional Movement Disorders  &#124; Congress 2026</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-functional-movement-disorders-congress-2026/</link>
	<pubDate>Mon, 26 Oct 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-functional-movement-disorders-congress-2026/</guid>
	<description><![CDATA[Ms. Nicole Duff discusses with Dr. Sara Lidstone the diagnosis and management of functional neurological and movement disorders, including clinical signs, patient-centered communication, and the importance of interdisciplinary rehabilitation.]]></description>
	<itunes:subtitle><![CDATA[Ms. Nicole Duff discusses with Dr. Sara Lidstone the diagnosis and management of functional neurological and movement disorders, including clinical signs, patient-centered communication, and the importance of interdisciplinary rehabilitation.]]></itunes:subtitle>
	<content:encoded><![CDATA[Ms. Nicole Duff discusses with Dr. Sara Lidstone the diagnosis and management of functional neurological and movement disorders, including clinical signs, patient-centered communication, and the importance of interdisciplinary rehabilitation.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Functional-Movement-Disorders.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Ms. Nicole Duff discusses with Dr. Sara Lidstone the diagnosis and management of functional neurological and movement disorders, including clinical signs, patient-centered communication, and the importance of interdisciplinary rehabilitation.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Ms. Nicole Duff discusses with Dr. Sara Lidstone the diagnosis and management of functional neurological and movement disorders, including clinical signs, patient-centered communication, and the importance of interdisciplinary rehabilitation.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Updates in Huntington&#8217;s Disease &#124; Congress 2026</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-updates-in-huntingtons-disease-congress-2026/</link>
	<pubDate>Wed, 21 Oct 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-updates-in-huntingtons-disease-congress-2026/</guid>
	<description><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Dr. Samuel Kim recent advances in Huntington’s disease, including genetic mechanisms, emerging biomarkers, and the potential of huntingtin-lowering therapies and gene therapy.]]></description>
	<itunes:subtitle><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Dr. Samuel Kim recent advances in Huntington’s disease, including genetic mechanisms, emerging biomarkers, and the potential of huntingtin-lowering therapies and gene therapy.]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Dr. Samuel Kim recent advances in Huntington’s disease, including genetic mechanisms, emerging biomarkers, and the potential of huntingtin-lowering therapies and gene therapy.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Ep-333---Eduardo-de-Pablo-Fernandez-and-Samuel-Kim.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Dr. Samuel Kim recent advances in Huntington’s disease, including genetic mechanisms, emerging biomarkers, and the potential of huntingtin-lowering therapies and gene therapy.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Dr. Samuel Kim recent advances in Huntington’s disease, including genetic mechanisms, emerging biomarkers, and the potential of huntingtin-lowering therapies and gene therapy.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Focused ultrasound &#124; Congress 2026</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-focused-ultrasound-congress-2026/</link>
	<pubDate>Wed, 21 Oct 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-focused-ultrasound-congress-2026/</guid>
	<description><![CDATA[Dr. Mitra Afshari discusses with Dr. Raul Martínez-Fernández recent advances in MRI-guided focused ultrasound for essential tremor and Parkinson’s disease, including improvements in safety and efficacy, its relationship with deep brain stimulation, and emerging neuromodulation approaches.]]></description>
	<itunes:subtitle><![CDATA[Dr. Mitra Afshari discusses with Dr. Raul Martínez-Fernández recent advances in MRI-guided focused ultrasound for essential tremor and Parkinson’s disease, including improvements in safety and efficacy, its relationship with deep brain stimulation, and e]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Mitra Afshari discusses with Dr. Raul Martínez-Fernández recent advances in MRI-guided focused ultrasound for essential tremor and Parkinson’s disease, including improvements in safety and efficacy, its relationship with deep brain stimulation, and emerging neuromodulation approaches.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/334---Focused-Ultrasound.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Mitra Afshari discusses with Dr. Raul Martínez-Fernández recent advances in MRI-guided focused ultrasound for essential tremor and Parkinson’s disease, including improvements in safety and efficacy, its relationship with deep brain stimulation, and emerging neuromodulation approaches.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Mitra Afshari discusses with Dr. Raul Martínez-Fernández recent advances in MRI-guided focused ultrasound for essential tremor and Parkinson’s disease, including improvements in safety and efficacy, its relationship with deep brain stimulation, and emerging neuromodulation approaches.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast PD biomarkers &#124; Congress 2026</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-pd-biomarkers-congress-2026/</link>
	<pubDate>Mon, 19 Oct 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-pd-biomarkers-congress-2026/</guid>
	<description><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic approaches.]]></description>
	<itunes:subtitle><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic approaches.]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic approaches.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/331-PD-Biomarkers.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic approaches.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic approaches.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Understanding Frailty in Parkinsonism &#124; Congress 2026</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-understanding-frailty-in-parkinsonism-congress-2026/</link>
	<pubDate>Mon, 19 Oct 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-understanding-frailty-in-parkinsonism-congress-2026/</guid>
	<description><![CDATA[Ms. Nicole Duff discusses with Dr. Alison Yarnall the prevalence and impact of frailty in Parkinsonism, including how it is identified and measured and its implications for clinical trials and patient care.]]></description>
	<itunes:subtitle><![CDATA[Ms. Nicole Duff discusses with Dr. Alison Yarnall the prevalence and impact of frailty in Parkinsonism, including how it is identified and measured and its implications for clinical trials and patient care.]]></itunes:subtitle>
	<content:encoded><![CDATA[Ms. Nicole Duff discusses with Dr. Alison Yarnall the prevalence and impact of frailty in Parkinsonism, including how it is identified and measured and its implications for clinical trials and patient care.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/332---Understanding-Frailty-in-Parkinsonism.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Ms. Nicole Duff discusses with Dr. Alison Yarnall the prevalence and impact of frailty in Parkinsonism, including how it is identified and measured and its implications for clinical trials and patient care.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Ms. Nicole Duff discusses with Dr. Alison Yarnall the prevalence and impact of frailty in Parkinsonism, including how it is identified and measured and its implications for clinical trials and patient care.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>MDS Podcast Parkinson&#8217;s disease genetics: What&#8217;s new &#124; Congress 2026</title>
	<link>https://podcastdemedicina.com/podcast/mds-podcast-parkinsons-disease-genetics-whats-new-congress-2026/</link>
	<pubDate>Thu, 15 Oct 2026 05:00:00 +0000</pubDate>
	<dc:creator><![CDATA[Podcast de Medicina · by casiMedicos]]></dc:creator>
	<guid isPermaLink="false">https://podcastdemedicina.com/podcast/mds-podcast-parkinsons-disease-genetics-whats-new-congress-2026/</guid>
	<description><![CDATA[Dr. Ignacio Mata discusses with Dr. Divyani Garg the dramatic increases in genetic testing globally over the last several years that have enhanced our understanding of the genetic architecture of Parkinson&#8217;s disease.]]></description>
	<itunes:subtitle><![CDATA[Dr. Ignacio Mata discusses with Dr. Divyani Garg the dramatic increases in genetic testing globally over the last several years that have enhanced our understanding of the genetic architecture of Parkinson&#8217;s disease.]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Ignacio Mata discusses with Dr. Divyani Garg the dramatic increases in genetic testing globally over the last several years that have enhanced our understanding of the genetic architecture of Parkinson&#8217;s disease.]]></content:encoded>
	<enclosure url="https://www.movementdisorders.org/MDS-Files1/Podcasts/Parkinsons-disease-genetics_-Whats-new.mp3" length="0" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Ignacio Mata discusses with Dr. Divyani Garg the dramatic increases in genetic testing globally over the last several years that have enhanced our understanding of the genetic architecture of Parkinson&#8217;s disease.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>0:00</itunes:duration>
	<itunes:author><![CDATA[Podcast de Medicina · by casiMedicos]]></itunes:author>	<googleplay:description><![CDATA[Dr. Ignacio Mata discusses with Dr. Divyani Garg the dramatic increases in genetic testing globally over the last several years that have enhanced our understanding of the genetic architecture of Parkinson&#8217;s disease.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>
	</channel>
</rss>
